NasdaqGS - Nasdaq Real Time Price USD

Lifecore Biomedical, Inc. (LFCR)

6.38

+0.21

+(3.40%)

At close: April 25 at 4:00:02 PM EDT

6.41

+0.03

+(0.47%)

After hours: April 25 at 5:59:00 PM EDT

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO Live 2025 conference. Billed as a premiere partnering event for the biopharma outsourcing industry, CDMO Live will take place May 7-8, 2025, in Rotterdam, Netherlands. During the conference, Jackie Klecker, Lifecore’s executive vice president,

GlobeNewswire 5 days ago

LFCR
+3.40%
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (“RSU”) award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stock, an RSU for 170,000 shares of common stock, and a performance stock unit (“PSU”) award for up to 370,000 shares of its common stock to Thomas D. Salus

GlobeNewswire 11 days ago

LFCR
+3.40%
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional Activities, and SEC Reporting and Compliance CHASKA, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has app

GlobeNewswire 13 days ago

LFCR
+3.40%
China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz

The major averages were sharply lower again near noon, continuing yesterday’s post-tariff slide. China has retaliated with additional tariffs of 34% on all U.S. goods a day after the Trump administration imposed its own sweeping levies. Meanwhile, the latest U.S. jobs data show that nonfarm payrolls rose by a higher-than-forecast 228,000 jobs, though the unemployment rate has ticked higher. Looking to commodities, oil prices are sharply lower due to a planned output increase promised by OPEC+ as

TipRanks 22 days ago

APP

BKNG

GME
Lifecore Biomedical Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Lifecore Biomedical ( NASDAQ:LFCR ) Third Quarter 2025 Results Key Financial Results Revenue: US$35.2m (down 1.5% from...

Simply Wall St. 22 days ago

LFCR
+3.40%
Q3 2025 Lifecore Biomedical Inc Earnings Call

Q3 2025 Lifecore Biomedical Inc Earnings Call

Thomson Reuters StreetEvents 23 days ago

LFCR
+3.40%
Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ...

Despite a challenging quarter, Lifecore Biomedical Inc (LFCR) focuses on new agreements and operational improvements to drive future growth.

GuruFocus.com 23 days ago

LFCR
+3.40%
Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of -35.71% and 3.95%, respectively, for the quarter ended February 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 24 days ago

LFCR
+3.40%
Lifecore Biomedical: Fiscal Q3 Earnings Snapshot

LFCR) on Thursday reported a loss of $14.8 million in its fiscal third quarter. The Chaska, Minnesota-based company said it had a loss of 47 cents per share. Losses, adjusted for non-recurring costs, came to 19 cents per share.

Associated Press Finance 24 days ago

LFCR
+3.40%
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital Equipment, Raising Approximately $17.0 Million -- Conference Call Today at 4:30pm ET CHASKA, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced its financial r

GlobeNewswire 24 days ago

LFCR
+3.40%
Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

Webcast Scheduled for Thursday, April 3 at 4:30 p.m. EasternCHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discus

GlobeNewswire last month

LFCR
+3.40%
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch CHASKA, Minn. and MINNEAPOLIS, March 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and Humanetics Corporation (“Humanetics”), an advanced cl

GlobeNewswire last month

LFCR
+3.40%
Is Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now?

We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where Lifecore Biomedical, Inc. (NASDAQ:LFCR) stands against the other micro cap stocks. Just as we overlook loose change, micro-cap stocks are often ignored for larger, more dominant enterprises. Investors trying […]

Insider Monkey last month

LFCR
+3.40%
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. The firm stated in its Q3 2024 letter that with a concentrated portfolio of idiosyncratic companies returns are expected to come in chunks, with progress being made and multiple multi-baggers holding potential. The […]

Insider Monkey last month

LFCR
+3.40%
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences and industry events. Details regarding Lifecore’s participation are as follows: TD Cowen 45th Annual Health Care ConferenceDetails: Paul Josephs, chief executive officer, will deliver a corporate presentation and Lifecore m

GlobeNewswire last month

LFCR
+3.40%
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 2025 BIO CEO & Investor Conference. The conference will take place February 10-11, 2025, in New York, NY. Details regarding Lifecore’s participation are as follows: 2025 BIO CEO & Investor ConferenceDetails: Lifecore management, including Paul Josephs, chief

GlobeNewswire 2 months ago

LFCR
+3.40%
This Lifecore Biomedical Insider Increased Their Holding In The Last Year

Insiders were net buyers of Lifecore Biomedical, Inc.'s ( NASDAQ:LFCR ) stock during the past year. That is, insiders...

Simply Wall St. 2 months ago

LFCR
+3.40%
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR)

Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, Class A interests in Laughing Water Capital returned about 18.6% bringing year-to-date returns to approximately 39.5%. The SP500TR and R2000 returned 2.4% and 0.3% in the quarter and 25% […]

Insider Monkey 3 months ago

LFCR
+3.40%
Lifecore Biomedical Announces Special Stockholder Meeting

Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock TermsCHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it intends to hold a special meeting of its stockholders (the “Special Meeting”) on April 10, 2025 (the “Special Me

GlobeNewswire 3 months ago

LFCR
+3.40%
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a sales agreement with a non-competitive buyer for the company’s previously purchased, but not yet installed, high-speed, mu

GlobeNewswire 3 months ago

LFCR
+3.40%

Performance Overview

Return	LFCR	S&P 500 (^GSPC)
YTD	-14.13%	-6.06%
1-Year	-3.92%	+9.44%
3-Year	-37.08%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz

Lifecore Biomedical Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Q3 2025 Lifecore Biomedical Inc Earnings Call

Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ...

Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates

Lifecore Biomedical: Fiscal Q3 Earnings Snapshot

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

Is Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now?

Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)

Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

This Lifecore Biomedical Insider Increased Their Holding In The Last Year

Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR)

Lifecore Biomedical Announces Special Stockholder Meeting

Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

Performance Overview